Skip to main content
Figure 3 | Thrombosis Journal

Figure 3

From: Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs

Figure 3

Representation of the mean ± S.E.M. of the thrombotic profiles of the blood of 5 individuals treated with vehicle control, aspirin (325 mg/day for 3 days), aspirin + PRT060128 (2.5 μM spiked in vitro ), eptifibatide (0.5 and 2.4 μM) after 150 sec (A), 200 sec (B), 300 sec (C) and 500 sec (D). Asterisks indicate cessation of blood perfusion following capillary occlusion. Two out of the 5 capillaries occluded in the 0.5 μM eptifibatide group (**).

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us